The legislation deals blow to the industry by narrowing the definition of a patentable compound. Simply applying reverse engineering to patented drugs and producing copycat generics will no longer be allowed. India has the world's fourth-largest pharmaceutical industry in terms of volume behind the United States, the European Union, and Japan. It is worth $7 billion now and is projected to grow to $35 billion by 2010, according to McKinsey and Co.
Source: Red Herring
Source: Red Herring
